top of page

Silo Wellness CEO Mike Arnold to Speak at the 2022 Missouri Psychedelic Advocacy Conference

Press Release: Silo Wellness CEO Mike Arnold to Speak at the 2022 Missouri Psychedelic Advocacy Conference

November 17, 2022 - Kansas City, MO – Crossing Paths Political Action Committee announced today that Silo Wellness CEO Mike Arnold confirmed his attendance at the 2022 Missouri Psychedelic Advocacy Conference this Saturday, Nov. 19th, at the University of Missouri-Columbia. The 2022 Missouri Psychedelic Advocacy Conference is a joint collaboration of Crossing Paths PAC and the University of Missouri-Columbia chapter of Young Americans for Liberty.

“We are proud to work with Mike Arnold, the first Missouri entrepreneur to start a publicly traded psychedelic medicine company,” said Crossing Paths PAC outreach director and lobbyist Eapen Thampy. “Mike’s leadership in this emerging field of science and medicine has sparked great interest in the benefits of legalizing psilocybin and other investigational psychedelic therapies across our state, and particularly in our veteran population.”

Arnold, of Parkville, Missouri, and a graduate of Truman State University (Kirksville, MO), founded Silo Wellness in Oregon in 2018 after having what he described as a life-changing experience with psilocybin. He initially focused on product development of psilocybin metered dosing modalities, and then the Company began cultivating psilocybin mushrooms in Jamaica in anticipation of Oregon being the first market to legalized. From there they launched the Silo Wellness psychedelic retreat system with psilocybin retreats in Jamaica and ketamine-assisted psychedelic therapy retreats in Oregon. Silo has hosted 5-MeO-DMT retreats in Jamaica as well. Silo is listed on the Canadian Securities Exchange (CSE: SILO) and is traded on the OTCQB in the United States under the SILFF ticker symbol.

“Missouri veterans demand access to psychedelic medicine,” said Silo Wellness Advisory Board member Elaine Brewer of Chesterfield, Missouri. “Missouri has a population of over 400,000 military veterans representing roughly 8% of our population, and we must do more to ensure they have access to psychedelic therapies that offer real solutions to issues of PTSD and other wartime traumas. We look forward to developing options with Silo Wellness that can offer these services as Oregon and Colorado have changed their state laws. Also, the Food & Drug Administration is considering federally rescheduling both psilocybin and MDMA in the next few years.” Brewer founded the Humble Warrior Wellness Center, a 501(c)(3) nonprofit serving war veterans and their families.

“It is important to see momentum out of Missouri from companies like Silo Wellness and advocates in the Missouri General Assembly for this important issue that is key to providing population level solutions to mental health crises in America,” said Silo Wellness advisory member Dr. Josh Siegel MD/PhD of St. Louis. “I look forward to providing input to the Silo Wellness team as clinical research continues to expand.”

Silo Wellness recently entered into a binding term sheet for a joint venture with New Frontier Ranch in the majestic Green Springs area of Jackson County Oregon, east of Ashland, pending the results of action by Jackson County on approving psilocybin retreats zoning. New Frontier Ranch is a 960-acre property that can potentially accommodate hundreds of guests at a time between the existing log cabin houses and court-approved campsites.

“I am excited to return to my home state and continue working with Missourians advocating for change in state law as these therapies become more accessible,” said Arnold. “Missouri has an opportunity to continue leading the way nationally as we develop clinical and therapeutic protocols for psychedelic access and delivery. ”

More information about the 2022 Missouri Psychedelic Advocacy Conference, including a list of speakers and how to attend, is available at

Contact: Eapen Thampy, 573-673-5351,

85 views0 comments

Recent Posts

See All


bottom of page